Pulmonary Hypertension (PH) is a complex and progressive disease characterized by elevated pulmonary artery pressure. This guide aims to provide a comprehensive understanding of the disease's pathophysiology, diagnosis, and treatment options.
PH is primarily a disorder of the small pulmonary arteries, resulting in their narrowing or obliteration. This causes an increase in pulmonary vascular resistance, leading to right ventricular overload and eventually right heart failure. The pathogenesis is multifactorial, involving genetic predisposition, endothelial dysfunction, and inflammatory processes.
Diagnosis of PH is challenging due to its non-specific symptoms. A high index of clinical suspicion is necessary in patients presenting with dyspnea, chest pain, or syncope. Diagnostic modalities include echocardiography, right heart catheterization, and pulmonary function tests. Biomarkers such as N-terminal pro b-type natriuretic peptide (NT-proBNP) can also aid in the diagnosis and prognostication.
Treatment of PH is aimed at improving symptoms, slowing disease progression, and enhancing survival. It involves general measures, drug therapy, and in severe cases, lung transplantation. Pharmacological therapy includes endothelin receptor antagonists, phosphodiesterase type 5 inhibitors, and prostacyclin analogs. Emerging therapies targeting the inflammatory and metabolic aspects of the disease are currently under investigation.
Healthcare professionals play a critical role in the early identification, management, and follow-up of patients with PH. Multidisciplinary approach involving cardiologists, pulmonologists, radiologists, and pathologists is often necessary. Regular patient education and counseling are also integral components of management.
In conclusion, PH is a complex disease requiring a comprehensive understanding of its pathophysiology, diagnostic approaches, and treatment options. Early recognition and appropriate management by healthcare professionals can significantly improve patient outcomes.
1.
Examines Office-Based Transperineal Prostate Biopsies Methodology.
2.
Retifanlimab-Chemo Combo Boosts PFS in Advanced Squamous Cell Anal Cancer
3.
Next Day Mood Is Affected by Ability to Recover From Work.
4.
Chicken Broth Recall; Medicaid at Risk; Princess Kate Thanks Medical Staff
5.
Study links persistent fatigue in breast cancer survivors to increased inflammation
1.
Surgical Innovation Using Tumor-Adaptive Surgical Resection Strategies
2.
Understanding Dasatinib: A Promising Drug for Cancer Treatment
3.
Revolutionizing Oncology: AI in Radiology, Machine Learning in Pathology, and Deep Learning for Cancer Detection
4.
The Growing Crisis of Aplastic Anemia: A Call for Action
5.
Unlocking the Power of Hematocrit: Exploring the Benefits of Blood Cell Counts
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Signs and Symptoms of Leukemia
2.
From Relapse to Remission : Chasing the Invisible and Redefining Long-Term Survival in Adult R/R B-Cell ALL
3.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part V
4.
Benefits of Treatment with CDK4/6 Inhibitors in HR+/HER2- aBC in Clinical Trials and the Real World
5.
Immunotherapy: A New Era in Cancer Treatment
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation